Lanticse, Saturnino A.
HRN: 12-17-46 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/21/2022
CEFTRIAXONE 1G (VIAL)
11/21/2022
11/27/2022
IV
2g
Q 24H
Infected Wound, R Foot
Waiting Final Action
Indication: Empiric Type of Infection: Bone & Joint Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes